rs773405046
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3
The NM_206933.4(USH2A):c.5855C>T(p.Ala1952Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000093 in 1,613,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A1952A) has been classified as Uncertain significance.
Frequency
Consequence
NM_206933.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.5855C>T | p.Ala1952Val | missense_variant, splice_region_variant | Exon 29 of 72 | ENST00000307340.8 | NP_996816.3 | |
USH2A-AS2 | NR_125992.1 | n.136+291G>A | intron_variant | Intron 1 of 2 | ||||
USH2A-AS2 | NR_125993.1 | n.136+291G>A | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152070Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 250772 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461340Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727018 show subpopulations
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74262 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on splicing; In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1952 of the USH2A protein (p.Ala1952Val). This variant is present in population databases (rs773405046, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 517240). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Usher syndrome type 2A Uncertain:2
- -
- -
not specified Uncertain:1
The p.Ala1952Val variant in USH2A has not been previously reported in individual s with hearing loss. This variant has been identified in 3/10332 of African chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs773405046). Although this variant has been seen in the general popula tion, its frequency is not high enough to rule out a pathogenic role. Computatio nal prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. This variant affects a nucleotide position located in the 5' splice region; however, computational tools do not provide st rong support for or against an impact to splicing. In summary, the clinical sign ificance of the p.Ala1952Val variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.5855C>T (p.A1952V) alteration is located in exon 29 (coding exon 28) of the USH2A gene. This alteration results from a C to T substitution at nucleotide position 5855, causing the alanine (A) at amino acid position 1952 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Retinitis pigmentosa 39 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at